Manufactured by:ProteoGenix
Save 20%RUO

Recombinant Human IL2 Protein, C-His

Recombinant Human IL2 Protein, C-His from ProteoGenix; catalogue ARO-P10409; research use only.

SKU:
ABM140849-1
Manufacturer SKU
ARO-P10409
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Introduction to Recombinant Human IL2 Protein

Recombinant Human IL2 Protein, also known as interleukin-2, is a cytokine protein that plays a crucial role in the immune system. It is produced by activated T cells and acts as a growth factor for various immune cells, including T cells, B cells, and natural killer cells. The recombinant form of this protein is produced through genetic engineering techniques and has been widely used in research and clinical applications. In this article, we will delve into the structure, activity, and applications of Recombinant Human IL2 Protein.

Structure of Recombinant Human IL2 Protein

Recombinant Human IL2 Protein is composed of 133 amino acids and has a molecular weight of approximately 15 kDa. It is a homodimer, meaning it consists of two identical subunits. Each subunit has a four-helix bundle structure and contains two disulfide bonds that are crucial for its stability. The protein also has a hydrophobic core that is responsible for its structural stability. Recombinant Human IL2 Protein is highly conserved among different species, with human and mouse IL2 proteins sharing 56% sequence identity.

Activity of Recombinant Human IL2 Protein

The main function of Recombinant Human IL2 Protein is to regulate the immune response. It acts as a growth factor for T cells, promoting their proliferation, differentiation, and survival. This cytokine also plays a crucial role in the activation and expansion of natural killer cells, which are essential for the body’s defense against viruses and tumors. Additionally, Recombinant Human IL2 Protein has been shown to enhance the activity of B cells, leading to increased antibody production. It also has anti-inflammatory properties and can modulate the activity of regulatory T cells, which are essential for maintaining immune tolerance.

Applications of Recombinant Human IL2 Protein

Recombinant Human IL2 Protein has a wide range of applications in both research and clinical settings. In research, it is commonly used as a growth factor to stimulate the proliferation of T cells in cell culture experiments. It is also used to expand the number of T cells in adoptive cell therapy, a promising immunotherapy approach for cancer treatment. Additionally, Recombinant Human IL2 Protein is used in studies to investigate the role of T cells in various diseases and to understand the mechanisms of immune response regulation.

In clinical applications, Recombinant Human IL2 Protein has been approved by the FDA for the treatment of metastatic renal cell carcinoma and metastatic melanoma. It is administered as an injection and works by activating and expanding the patient’s own immune cells to fight against cancer cells. This therapy has shown promising results in clinical trials and has been used as a second-line treatment for patients who have not responded to other therapies.

Conclusion

In summary, Recombinant Human IL2 Protein is a crucial cytokine in the immune system, with multiple functions in regulating the immune response. Its homodimeric structure and conserved sequence make it an ideal candidate for genetic engineering techniques, leading to the production of recombinant forms for research and clinical use. Its applications in cancer treatment and immunotherapy have shown promising results and continue to be an area of active research. With its diverse functions and potential therapeutic applications, Recombinant Human IL2 Protein remains a significant protein in the field of immunology.

ProteoGenix catalogue number ARO-P10409. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 16.48 kDa; Fragment: Met1-Thr134; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
IL2, IL-2, Aldesleukin, Interleukin-2, TCGF, T-cell growth factor
Host species
E. coli
Source organism
Human
Molecular weight
16.48 kDa
Sequence fragment
Met1-Thr134
Sequence
MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADE
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P10409
UniProt accession
P60568
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
£215.00£172.00